Dr Joaquim Bellmunt is presently an Associate Professor at Harvard Medical School and Director of Bladder Cancer Center at Genitourinary Oncology Program of Dana-Farber Cancer Institute. He was the former Director of the Bladder Cancer Center at Beth Israel Deaconess Medical Center. His clinical expertise is in urological diseases, particularly prostate, bladder and kidney cancer. He has extensive experience treating prostate and bladder cancer patients and has been a key investigator in several trials conducted in this patient population. He has been involved in the development of immunotherapy in bladder cancer since its inception. He has participated on the two phase I trials with atezolizumab (Nature.
ServicesDana-Farber Cancer Institute provides oncology services in Boston, MA. Oncology includes the diagnosis and treatment of breast cancer, skin cancer, prostate cancer, and many other forms of cancer.
Contact Joaquim Bellmunt, MD, PhD at (877) 442-3324 for specific information about cancer treatment in Boston, MA.